Apyx Medical Corp. (APYX)
2.645
-0.04
(-1.67%)
USD |
NASDAQ |
Oct 30, 12:18
Apyx Medical Enterprise Value : 125.73M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 125.73M |
| October 28, 2026 | 122.36M |
| October 27, 2026 | 117.73M |
| October 26, 2026 | 116.05M |
| October 23, 2026 | 112.26M |
| October 22, 2026 | 113.94M |
| October 21, 2026 | 118.15M |
| October 20, 2026 | 115.20M |
| October 19, 2026 | 114.36M |
| October 16, 2026 | 119.84M |
| October 15, 2026 | 120.26M |
| October 14, 2026 | 120.68M |
| October 13, 2026 | 121.94M |
| October 12, 2026 | 124.05M |
| October 09, 2026 | 121.52M |
| October 08, 2026 | 111.83M |
| October 07, 2026 | 119.84M |
| October 06, 2026 | 119.63M |
| October 05, 2026 | 121.94M |
| October 02, 2026 | 119.84M |
| October 01, 2026 | 117.73M |
| September 30, 2026 | 115.62M |
| September 29, 2026 | 121.94M |
| September 28, 2026 | 117.73M |
| September 25, 2026 | 137.10M |
| Date | Value |
|---|---|
| September 24, 2026 | 131.63M |
| September 23, 2026 | 136.68M |
| September 22, 2026 | 136.68M |
| September 21, 2026 | 135.00M |
| September 18, 2026 | 141.32M |
| September 17, 2026 | 140.05M |
| September 16, 2026 | 139.21M |
| September 15, 2026 | 137.10M |
| September 14, 2026 | 139.63M |
| September 11, 2026 | 134.58M |
| September 10, 2026 | 134.16M |
| September 09, 2026 | 140.89M |
| September 08, 2026 | 140.89M |
| September 04, 2026 | 140.89M |
| September 03, 2026 | 141.32M |
| September 02, 2026 | 142.16M |
| September 01, 2026 | 140.89M |
| August 31, 2026 | 140.89M |
| August 28, 2026 | 142.16M |
| August 27, 2026 | 138.79M |
| August 26, 2026 | 140.89M |
| August 25, 2026 | 143.42M |
| August 24, 2026 | 142.16M |
| August 21, 2026 | 143.84M |
| August 20, 2026 | 140.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 208.60B |
| AngioDynamics, Inc. | 500.71M |
| Alphatec Holdings, Inc. | 2.245B |
| AtriCure, Inc. | 3.084B |
| Baxter International, Inc. | 18.83B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.072M |
| Revenue (Quarterly) | 13.88M |
| Total Expenses (Quarterly) | 17.13M |
| EPS Diluted (Quarterly) | -0.074 |
| Gross Profit Margin (Quarterly) | 39.59% |
| Profit Margin (Quarterly) | -22.13% |
| Earnings Yield | -7.63% |
| Normalized Earnings Yield | -7.622 |